Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Keros Therapeutics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.45 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 225179.88% year-over-year to 0.45; the TTM value through Dec 2025 reached 0.45, up 225179.88%, while the annual FY2025 figure was 0.51, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.45 in Q4 2025 per KROS's latest filing, up from 0.32 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.0 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.11, with a median of 0.03 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: surged 3870103.85% in 2022, then tumbled 146.3% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.07 in 2021, then dropped by 13.25% to 0.06 in 2022, then crashed by 99.33% to 0.0 in 2023, then tumbled by 146.3% to 0.0 in 2024, then surged by 225179.88% to 0.45 in 2025.
  • Per Business Quant, the three most recent readings for KROS's Asset Utilization Ratio are 0.45 (Q4 2025), 0.32 (Q3 2025), and 0.3 (Q2 2025).